|
Neurogen Auditors Add Going Concern Qualification To 10K
(InvesTrend Via Thomson Dialog NewsEdge)
March 24, 2008 (FinancialWire) Neurogen Corp.'s (NASDAQ: NRGN) auditors
added a "going concern" qualification to their opinion in the company's
2007 financial statements included in Neurogen's annual report on Form
10-K.
Auditors add a going concern qualification when they are concerned that
the company, based on its financials, lacks the ability to continue to
meet its obligations for the following year.
Branford, Connecticut-based Neurogen is a drug discovery and
development company with clinical programs in insomnia, Parkinson's
disease, restless legs syndrome, pain, anxiety, and schizophrenia.
The company focuses its small molecule drug discovery efforts on
specialist care indications with unmet medical need.
FinancialWire is a fully independent, proprietary news wire service of
Investrend Information, a division of Investrend Communications, Inc.
It is not a press release service and receives no compensation from any
company for its news or opinions. All FinancialWire news is available
at http://www.financialwire.net . The FinancialWire NewsFeed is
available in multiple formats at
http://www.investrend.com/XmlFeeds?level=268 . Please address any
inquiries to feedback@financialwire.net . Free annual reports for
companies mentioned in the news are available at
http://investrend.ar.wilink.com/?level=279 .
(Distributed for Investrend Communications, Inc. via M2 Communications
Ltd (www.m2.com))
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|